Sanj K. Patel, Chairman & CEO at Kiniksa Pharmaceuticals, Ltd. (KNSA), sold 350,902 shares at $21.02 ($7.4M) on 2020-10-12, disclosed to the SEC on 2020-10-14.
Open-market sale of $7.4M KNSA by Chairman & CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.00 | 670 | $14K | 0.2% |
| 2 | $21.00 | 872 | $18K | 0.2% |
| 3 | $21.02 | 99,330 | $2.1M | 28.3% |
| 4 | $21.02 | 99,330 | $2.1M | 28.3% |
| 5 | $21.02 | 150,700 | $3.2M | 42.9% |
| Total | $21.02 avg | 350,902 |
| $7.4M |
| 100% |
| Filing → |
| KNSA | SELL | 2026-04-08 | $364K | — | Filing → |
| KNSA | SELL | 2025-10-22 | $20.0M | — | Filing → |
| KNSA | SELL | 2025-05-28 | $4.6M | — | Filing → |